Stenotrophomonas maltophilia DZ4 and application of stenotrophomonas maltophilia DZ4 in prevention and treatment of tobacco mosaic virus
By screening and applying maltophila DZ4, a bacterial agent was prepared to inhibit tobacco mosaic virus, achieving a 75% inhibition rate, solving the problem of tobacco mosaic virus prevention and control, and reducing the environmental impact of chemical pesticides Pollution meets the requirements of green prevention and control.
Patent Information
- Application Number
- CN202410888330.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-04
- Publication Date
- 2024-11-01
AI Technical Summary
The existing technology cannot effectively prevent and control tobacco mosaic viruses, and chemical pesticides are seriously polluted by soil and environment, and there is a lack of green prevention and control measures.
Monassium maltophila DZ4 was screened and used as a natural antagonist to prepare a bacterial agent to inhibit tobacco mosaic virus, and provide antagonistic effects through live pure culture and fermentation products.
The bacteria agent of Maltiophilus DZ4 has an average inhibitory rate of 75% on tobacco mosaic virus, reducing the risk of contamination of chemical pesticides, meeting the needs of green prevention and control, and avoiding drug resistance.
Smart Images

Figure CN118879531A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of microbial biological control, and specifically relates to Stenotrophomonas maltophilia DZ4 and application thereof in preventing and controlling tobacco mosaic virus. Background Art
[0002] Tobacco mosaic virus disease is a major tobacco disease caused by tobacco mosaic virus (TMV). TMV in infected tobacco is transmitted through mechanical friction. If TMV survives in the soil, it can infect tobacco through micro-wounds at the roots of tobacco. Excessive field operations also contribute to the spread of the virus, which increases the harm. After tobacco is infected with TMV, the leaves show mosaic symptoms, which seriously affects the quality of tobacco leaves and poses a great threat to tobacco production.
[0003] Viruses are obligate intracellular parasites. Once a tobacco plant is infected, there is no effective drug to completely control it in production. Screening for natural microbial antagonists that can be used to prevent and treat tobacco virus diseases can reduce the pollution of chemical pesticides to the soil and environment, which meets the needs of the country's green prevention and control development. Summary of the invention
[0004] The purpose of the present invention is to provide a Stenotrophomonas maltophilia DZ4 and its application in preventing and controlling tobacco mosaic virus in order to solve the above problems.
[0005] The present invention achieves the above-mentioned purpose through the following technical solutions:
[0006] The present invention provides a Stenotrophomonas maltophilia DZ4 (Stenotrophomonas maltophiliaDZ4). The living pure culture of the Stenotrophomonas maltophilia DZ4 has been registered and preserved in the China Center for Type Culture Collection (CCTCC). The preservation address is Wuhan University, No. 299, Bayi Road, Wuchang District, Wuhan City, Hubei Province. The preservation date is September 11, 2023, and the preservation number is CCTCCNO: M20231664.
[0007] The present invention also provides an application of the Stenotrophomonas maltophilia DZ4 in preventing and controlling tobacco mosaic virus.
[0008] As a further optimization scheme of the present invention, the Stenotrophomonas maltophilia DZ4 is prepared into a bacterial agent, and the bacterial agent has an antagonistic and inhibitory effect on the prevention and treatment of tobacco mosaic virus.
[0009] As a further optimization scheme of the present invention, the bacterial agent is a liquid preparation or a freeze-dried powder.
[0010] As a further optimization scheme of the present invention, the bacterial agent is a fermentation product of Stenotrophomonas maltophilia DZ4.
[0011] The present invention also provides a method for preventing and controlling tobacco mosaic virus, wherein the bacterial agent of Stenotrophomonas maltophilia DZ4 is applied to an object infected with tobacco mosaic virus.
[0012] The beneficial effects of the present invention are:
[0013] 1. The present invention obtains Stenotrophomonas maltophilia DZ4 that can inhibit tobacco mosaic virus through screening. Further experiments show that the average inhibition rate of Stenotrophomonas maltophilia DZ4 on tobacco mosaic virus reaches 75%, which provides a new option and idea for the prevention and treatment of tobacco mosaic virus.
[0014] 2. The Stenotrophomonas maltophilia DZ4 of the present invention is an antagonistic bacterium against TMV screened from the field. The screening and utilization of the Stenotrophomonas maltophilia DZ4 meet the needs of the national green prevention and control development, reduce the pollution of chemical pesticides to the soil and the environment, and avoid the problem of drug resistance of plant pathogens. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] Figure 1 This is a physical picture of Stenotrophomonas maltophilia DZ4;
[0016] Figure 2 is the inactivation graph of the antagonistic strain DZ4 and TMV virus and the negative control graph;
[0017] Figure 3 This is the Ningnanmycin and TMV passivation and negative control graphs. DETAILED DESCRIPTION
[0018] The present invention is further described below in conjunction with specific embodiments. The technical solutions of the present invention are conventional methods in the art unless otherwise specified, and the reagents or materials are conventional reagents and are sourced from commercial channels unless otherwise specified.
[0019] 1. Materials
[0020] Stenotrophomonas maltophilia DZ4 is a bacterium isolated from the root soil of healthy tobacco plants in a field with severe TMV disease. This strain is not a pathogenic bacterium.
[0021] 2. Methods
[0022] 2.1. Obtaining strains
[0023] (1) Sampling: Select healthy tobacco plants from tobacco fields where tobacco mosaic disease has occurred, and select rhizosphere soil from 20 cm below the roots of the tobacco plants for later use;
[0024] (2) Grinding: Place 10 g of the reserved soil in a sterilized Erlenmeyer flask, add 20 ml of sterile water, shake until the liquid becomes turbid, and leave it at room temperature for 10 minutes for later use;
[0025] (3) Purification: 200 μL of the liquid supernatant after quiescence was sucked up with a sterile pipette tip, and the plate method was used on NA medium (beef extract 3.0 g / L, sucrose 10.0 g / L, peptone 5.0 g / L, yeast extract 1.0 g / L, agar 15.0 g / L, pH = 7.1), and cultured at 28°C for 24 h. After the colonies grew on the separation plate, the isolated single colonies were picked out one by one with an inoculation loop according to the characteristics of the microbial colonies, such as morphology, size, surface structure, edge structure, texture, gloss, transparency, color and soluble pigment produced. The single colonies with different morphologies were picked out and streaked on the corresponding blank NA medium plates for purification, and then inverted and cultured in a constant temperature incubator at 28°C for 24 h to obtain the purified strains for later use.
[0026] (4) Screening: Select a single bacterial colony and place it in a sterilized 100-ml conical flask containing 20 ml of culture medium. Culture with shaking (28°C, 200 r / min) for 24 h to ensure that the bacterial liquid content is large enough to be used as a fermentation strain.
[0027] 2.2 Identification of bacterial species
[0028] The strain obtained in 2.1 was used as raw material, and physiological, biochemical and molecular biological identifications were performed according to conventional microbial identification methods. The strain DZ4 obtained in this screening was found to have an oval, smooth and uniform colony, milky white, and Gram-negative.
[0029] The pathogen DNA was extracted using Wizard genomic DNA purification kit (Promega, Madison, WI). The primers were used for PCR amplification to obtain the 16SrDNA gene. The PCR reaction system was: 50 μL (10×PCR buffer 5 μL, dNTP 1 μL, P0 2 μL, P6 2 μL, Tag enzyme 1 μL, template DNA 2 μL, dd H2O3 7 μL), and the PCR amplification conditions were: 94℃5min; 94℃30s, 55℃1min, 72℃90s, 30 cycles; 72℃1min; 10℃20min.
[0030] The 16SrDNA gene primers are as follows:
[0031] SEQ ID NO.2: 7F: CAGAGTTTGATCCTGGCT;
[0032] SEQ ID NO. 3: 1540R: AGGAGGGTGATCCAGC.
[0033] The obtained 16SrDNA gene was sequenced, and the sequencing result was SEQ ID No.1.
[0034] The sequencing results of 16S rDNA gene were compared with BLAST software on the NCBI website, and the pathogen was preliminarily identified as Stenotrophomonas maltophilia, named Stenotrophomonas maltophilia DZ4.
[0035] (Stenotrophomonas maltophilia DZ4), e.g. Figure 1 The living pure culture of Stenotrophomonas maltophilia DZ4 was deposited in the China Center for Type Culture Collection (address: Wuhan University, No. 299, Bayi Road, Wuchang District, Wuhan City, Hubei Province) on September 11, 2023, with the deposit number: CCTCC M 20231664.
[0036] 2.3 Comparison of the inhibitory effects of DZ4 and Ningnanmycin on TMV infection
[0037] The half-leaf method was used to determine the inhibition rate of DZ4 on TMV infection using the allergic necrosis reaction of Nicotiana tabacum var.samsun NN to TMV.
[0038] 2.3.1. Preparation of virus samples
[0039] The young leaves of the TMV virus source that were fully infected were ground and filtered with distilled water at a ratio of 1:10 (mass to volume) to serve as the virus sample for the test.
[0040] The DZ4 to be tested was mixed with the virus sample in equal volumes, and after 30 minutes, it was inoculated by friction into the right half of some dead spots of Sansheng tobacco.
[0041] Ningnanmycin was mixed with the virus sample in equal volumes and inoculated into the right half leaf of the remaining Nicotiana tabacum after 30 minutes by friction.
[0042] The liquid NA medium was mixed with the virus sample in equal volumes, and 30 minutes later, the left half leaf of the DZ4 / Ningnanmycin+virus-treated Nicotiana tabacum was rubbed.
[0043] After the necrosis spots appeared, the number of necrosis spots on the left and right half leaves was recorded. The experiment was repeated three times, and three leaves were inoculated on each tobacco plant.
[0044] The inhibition rate (%) was calculated based on the number of dead spots on the left and right halves of the test record, and the average inhibition rate of three repeated tests was calculated. The inhibition rate calculation formula is:
[0045] Inhibition rate (%) = [(number of control necrosis spots - number of treated necrosis spots) / number of control necrosis spots] × 100%.
[0046] The results are shown in the following table:
[0047]
[0048] From the table above, we can see that the inhibition rate of DZ4 fermentation broth on TMV is about 75%, which is much higher than the 54% inhibition rate achieved by Ningnanmycin. Figure 2 and 3 As shown, it was shown that the bacterial agent of Stenotrophomonas maltophilia DZ4 could have a significant antagonistic inhibitory effect on tobacco mosaic virus.
[0049] The above-mentioned embodiments only express several implementation methods of the present invention, and the description thereof is relatively specific and detailed, but it cannot be understood as limiting the scope of the present invention. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, which all belong to the protection scope of the present invention.
Claims
1. A Stenotrophomonas maltophilia DZ4, characterized in that The live pure culture of Stenotrophomonas maltophilia DZ4 has been registered and preserved in the China Center for Type Culture Collection (CCTCC) with a preservation date of September 11, 2023 and a preservation number of CCTCCNO: M20231664.
2. Use of Stenotrophomonas maltophilia DZ4 as claimed in claim 1 in preventing and controlling tobacco mosaic virus.
3. The use according to claim 2, characterized in that: The Stenotrophomonas maltophilia DZ4 is prepared into a bacterial agent, and the bacterial agent has an antagonistic and inhibitory effect on tobacco mosaic virus.
4. The use according to claim 3, characterized in that: The bacterial agent is a liquid preparation or a freeze-dried powder.
5. The use according to claim 3, characterized in that: The bacterial agent is a fermentation product of Stenotrophomonas maltophilia DZ4.
6. A method for preventing and treating tobacco mosaic virus, characterized in that: The bacterial agent prepared by Stenotrophomonas maltophilia DZ4 according to claim 3 is administered to a subject infected with tobacco mosaic virus.
Citation Information
Cited By
Application of stenotrophomonas maltophilia in prevention and treatment of pepper mild mottle virus
CN118909826A
Application of Stenotrophomonas maltophilia in the prevention and control of pepper mild mottle virus
CN118909826B
